Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P51532 (
transcriptional activator
)
6,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have identified two novel human SCAN domain genes
ZNF396
and ZNF397, which are clustered within the region of chromosome 18q12. Three isoforms of
ZNF396
transcript, 1.5, 2.5 and 3.9-kb, are expressed highly in liver. Four isoforms of ZNF397 transcript, 1.7, 2.5, 7.0 and 9.0-kb, are expressed in a variety of tissues, with varying levels. The SCAN-(C(2)H(2))(X) genes encode two distinct proteins due to a unique alternative splicing mechanism. Both
ZNF396
-fu (full zinc fingers) and ZNF397-fu consist of a SCAN domain in the N-terminal region and many consecutive C(2)H(2) zinc finger repeats in the C-terminal region.
ZNF396
-nf (no zinc fingers) and ZNF397-nf encode 210 and 198 amino acids, respectively, containing the SCAN domain only.
ZNF396
-fu,
ZNF396
-nf, ZNF397-fu or ZNF397-nf can homo-associate, while
ZNF396
-fu hetero-associates with
ZNF396
-nf, and ZNF397-fu hetero-associates with ZNF397-nf.
ZNF396
-nf and ZNF397-nf polypeptides are expressed diffusely in the cells, while
ZNF396
-fu and ZNF397-fu polypeptides target specifically to the nuclei.
ZNF396
-fu,
ZNF396
-nf and ZNF397-nf can repress reporter gene transcription, with ZNF397-nf having the strongest repression activity. Deletion analysis revealed that ZNF397-fu is a
transcriptional activator
without its nine zinc finger repeats.
...
PMID:Identification and characterization of two novel human SCAN domain-containing zinc finger genes ZNF396 and ZNF397. 1280 47